Why is Global Health falling/rising?

As of 20-Jun, Global Health Ltd's stock price is currently at 1,131.95, reflecting a decrease of 32.0 points or 2.75%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 7.1% during this period. Today's performance shows that it underperformed its sector by 3.66%, and it reached an intraday low of Rs 1,123.75. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. While the company has a high management efficiency with a return on equity (ROE) of 15.90% and low debt-to-equity ratio, it faces challenges due to a flat earnings report and a high price-to-book value ratio, indicating a premium valuation compared to peers. The stock's performance over the past year has also been poor, with a return of -14.14%, despite an 8.6% increase in profits, leading to a high PEG ratio of 6.8.
In the broader market context, Global Health's short-term performance has been notably weaker than the benchmark, as it has declined by 5.02% over the past week while the Sensex has increased by 1.59%. This trend of underperformance continues in the one-month period, where the stock is down 4.85% compared to a 1.50% rise in the Sensex. The significant drop in delivery volume, which has decreased by 70.47% against the 5-day average, suggests a lack of investor confidence, further contributing to the stock's decline. Overall, the combination of poor short-term performance, high valuation concerns, and declining investor participation paints a challenging picture for Global Health Ltd's stock.